Authors:
Staar, S
Rudat, V
Stuetzer, H
Dietz, A
Volling, P
Schroeder, M
Flentje, M
Eckel, HE
Mueller, RP
Citation: S. Staar et al., Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy - Results of a multicentric randomized German trial in advanced head-and-neck cancer (vol 50, pg 1161, 2001), INT J RAD O, 51(2), 2001, pp. 569-569
Authors:
Staar, S
Rudat, V
Stuetzer, H
Dietz, A
Volling, P
Schroeder, M
Flentje, M
Eckel, HE
Mueller, RP
Citation: S. Staar et al., Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy-results of a multicentric randomized German trial in advanced head-and-neck cancer, INT J RAD O, 50(5), 2001, pp. 1161-1171
Authors:
Sittel, C
Ruiz, S
Kvasnicka, HM
Volling, P
Jungehulsing, M
Eckel, HE
Citation: C. Sittel et al., Prognostic value of proliferation markers Ki-67 (MIB1), PCNA, and p53 in combined surgical and radiation therapy of carcinomas of the oropharynx and oral cavity., LARY RH OTO, 79(2), 2000, pp. 86-92
Authors:
Dietz, A
Rudat, V
Conradt, C
Vanselow, B
Wollensack, P
Staar, S
Eckel, H
Volling, P
Schroder, M
Wannenmacher, M
Muller, RP
Weidauer, H
Citation: A. Dietz et al., Prognostic significance of initial hemoglobin in head and neck cancer treated by primary chemoradiation, HNO, 48(9), 2000, pp. 655-664
Authors:
Eckel, HE
Streppel, M
Schmalenbach, K
Volling, P
Schrappe, M
Dietz, A
Bootz, F
Citation: He. Eckel et al., Quality assurance in head and neck surgical oncology: results of a German nationwide survey, HNO, 48(12), 2000, pp. 902-910
Authors:
Sittel, C
Ruiz, S
Volling, P
Kvasnicka, HM
Jungehulsing, M
Eckel, HE
Citation: C. Sittel et al., Prognostic significance of Ki-67 (MIB1), PCNA and p53 in cancer of the oropharynx and oral cavity, ORAL ONCOL, 35(6), 1999, pp. 583-589
Citation: P. Volling et O. Ebeling, Undesirable effects of cytostatic chemotherapy in patients with head-neck carcinomas. Prophylaxis and therapy, HNO, 47(11), 1999, pp. 999-1015
Authors:
Volling, P
Schroder, M
Eckel, H
Ebeling, O
Stennert, E
Citation: P. Volling et al., Results of a prospective randomized trial with induction chemotherapy for cancer of the oral cavity and tonsils, HNO, 47(10), 1999, pp. 899-906